RPG Life Sciences Clocks Lower Consolidated Net Profit in Fiscal Q3; Shares Slip 9%

MT Newswires Live

Jan 28

RPG Life Sciences (NSE:RPGLIFE, BOM:532983) reported a decline in its consolidated net profit to 221.3 million Indian rupees in the fiscal third quarter from 349.3 million rupees a year ago, according to a Tuesday filing with the Indian bourses.

Shares of the pharmaceutical company fell around 9% in early trade on Wednesday.

Earnings per share during the quarter ended Dec. 31, 2025, slipped to 13.38 rupees from 21.12 rupees a year earlier.

Revenue from operations in fiscal Q3 increased year on year to 1.80 billion rupees from 1.73 billion rupees, the filing said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2606764167"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2606764167\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2606764167?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-28 13:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606764167","market":"hk","top_or_hot":-1,"title":"RPG Life Sciences Clocks Lower Consolidated Net Profit in Fiscal Q3; Shares Slip 9%","media":"MT Newswires Live","content":"<html><body><p> RPG Life Sciences (NSE:RPGLIFE, BOM:532983) reported a decline in its consolidated net profit to 221.3 million Indian rupees in the fiscal third quarter from 349.3 million rupees a year ago, according to a Tuesday filing with the Indian bourses.</p><p>Shares of the pharmaceutical company fell around 9% in early trade on Wednesday.</p><p>Earnings per share during the quarter ended Dec. 31, 2025, slipped to 13.38 rupees from 21.12 rupees a year earlier.</p><p>Revenue from operations in fiscal Q3 increased year on year to 1.80 billion rupees from 1.73 billion rupees, the filing said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RPG Life Sciences Clocks Lower Consolidated Net Profit in Fiscal Q3; Shares Slip 9%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRPG Life Sciences Clocks Lower Consolidated Net Profit in Fiscal Q3; Shares Slip 9%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-28 13:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> RPG Life Sciences (NSE:RPGLIFE, BOM:532983) reported a decline in its consolidated net profit to 221.3 million Indian rupees in the fiscal third quarter from 349.3 million rupees a year ago, according to a Tuesday filing with the Indian bourses.</p><p>Shares of the pharmaceutical company fell around 9% in early trade on Wednesday.</p><p>Earnings per share during the quarter ended Dec. 31, 2025, slipped to 13.38 rupees from 21.12 rupees a year earlier.</p><p>Revenue from operations in fiscal Q3 increased year on year to 1.80 billion rupees from 1.73 billion rupees, the filing said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4115","symbol_name":"综合电信业务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2606764167","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606764167","pubTimestamp":1769579438,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"RPG Life Sciences  reported a decline in its consolidated net profit to 221.3 million Indian rupees in the fiscal third quarter from 349.3 million rupees a year ago, according to a Tuesday filing with the Indian bourses.Shares of the pharmaceutical company fell around 9% in early trade on Wednesday.Earnings per share during the quarter ended Dec. 31, 2025, slipped to 13.38 rupees from 21.12 rupees a year earlier.Revenue from operations in fiscal Q3 increased year on year to 1.80 billion rupees from 1.73 billion rupees, the filing said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4115":"综合电信业务","RPG":"Invesco S&P 500 Pure Growth ETF","CNSL":"联合通讯"},"translate_title":"RPG Life Sciences第三财季综合净利润下降；股价下跌9%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNSL":1.5,"RPG":1.5},"content_text":"RPG Life Sciences (NSE:RPGLIFE, BOM:532983) reported a decline in its consolidated net profit to 221.3 million Indian rupees in the fiscal third quarter from 349.3 million rupees a year ago, according to a Tuesday filing with the Indian bourses.Shares of the pharmaceutical company fell around 9% in early trade on Wednesday.Earnings per share during the quarter ended Dec. 31, 2025, slipped to 13.38 rupees from 21.12 rupees a year earlier.Revenue from operations in fiscal Q3 increased year on year to 1.80 billion rupees from 1.73 billion rupees, the filing said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}